文献速递心力衰竭与心肌病心律失常

肥厚型心肌病运动训练:随机试验的荟萃分析与试验序贯分析

Exercise training in hypertrophic cardiomyopathy: a meta-analysis of randomised trials with trial sequential analysis.
PubMed 文献 · Heart · 2025-11-30

该系统评价纳入4项随机对照试验(n=290),对象以低危、非梗阻性肥厚型心肌病患者为主,基线左心室射血分数均值66%。结构化运动可改善峰值摄氧量(MD 1.81 mL/kg/min;95%CI 1.01–2.61;p<0.01),并降低左心室壁厚度和体质指数,未增加心律失常、晕厥或心脏性猝死等不良事件。

要点

  • 运动训练可改善低危非梗阻性肥厚型心肌病患者的峰值摄氧量。
  • 运动训练未增加心律失常、晕厥或心脏性猝死等不良事件。
  • 结论主要适用于轻度、非梗阻性表型,推广需谨慎。

核心结论

  • 在轻度、非梗阻性肥厚型心肌病患者中,结构化运动训练似乎安全,可改善功能能力和心脏代谢指标,且未对心室产生不良影响。

研究设计与样本

  • 系统评价与荟萃分析,纳入比较结构化运动干预与常规护理的随机对照试验,共4项RCT、n=290,并应用随机效应模型和试验序贯分析(TSA)评估疗效与证据稳健性。

主要发现

  • 运动训练改善峰值摄氧量(MD 1.81 mL/kg/min;95%CI 1.01–2.61;p<0.01),该结果经TSA确认。
  • 运动训练降低左心室壁厚度(MD -0.56 mm;95%CI -0.97至-0.16)和体质指数(MD -0.65 kg/m²;95%CI -1.05至-0.25)。
  • 左心室射血分数和左心室流出道压差无显著变化。
  • 未观察到心律失常、晕厥、心脏性猝死或其他不良事件增加。

临床怎么用

  • 对于低危、非梗阻性、功能受限较轻的肥厚型心肌病患者,可考虑在评估后开展结构化运动训练以改善功能能力。
  • 对更高危表型(如梗阻性、高危及运动员等)患者,现有证据不足以支持广泛推荐运动训练,需个体化评估。

局限性

  • 纳入的RCT数量和参与者总数均较少。
  • 所有研究主要涉及轻度、非梗阻性表型,限制了结果的普遍性。
  • 需要更大规模、多中心、纳入更高危表型的RCT来确认安全性和明确最佳训练策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) among young individuals and athletes. Despite increasing evidence supporting exercise, uncertainty remains about its safety and efficacy in this population. METHODS: We systematically reviewed randomised controlled trials (RCTs) comparing structured exercise interventions with usual care in patients with HCM. The primary outcome was peak oxygen consumption (pVO₂). Random-effects meta-analysis and trial sequential analysis (TSA) were applied to assess efficacy and robustness of evidence. RESULTS: Four RCTs (n=290) were included, enrolling predominantly low-risk, non-obstructive HCM patients with mild functional limitation (mean left ventricular ejection fraction (LVEF) 66%). Exercise improved pVO₂ (mean difference (MD) 1.81 mL/kg/min; 95% CI 1.01 to 2.61; p<0.01), confirmed by TSA. Exercise also reduced left ventricular wall thickness (MD -0.56 mm; 95% CI -0.97 to -0.16) and body mass index (MD -0.65 kg/m²; 95% CI -1.05 to -0.25) without significant changes in LVEF or left ventricular outflow gradients. No increase was observed in arrhythmias, syncope, SCD or other adverse events. However, the total number of RCTs and participants was small, and all studies primarily involved mild, non-obstructive phenotypes, limiting generalisability. CONCLUSIONS: In patients with mild, non-obstructive HCM, structured exercise appears safe and improves functional capacity and cardiometabolic parameters without adverse ventricular effects. Larger multicentre RCTs including higher-risk phenotypes are warranted to confirm safety and define optimal training strategies. PROSPERO REGISTRATION NUMBER: CRD420251012232.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Correia VM, Morales Ribeiro V, Henkes Machado R, et al. Exercise training in hypertrophic cardiomyopathy: a meta-analysis of randomised trials with trial sequential analysis. Heart. 2025. PMID: 41320293. doi:10.1136/heartjnl-2025-326377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。